Binary mineral nanoparticles enable intravascular delivery of metal ions to tumors for metalloimmunotherapy.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 41526370.
- Also identified by DOI 10.1038/s41467-025-68279-y and PMC identifier 12895034.
- Licence recorded as CC BY-NC-ND.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Although disruptions in metal ion homeostasis leading to severe cellular damage and regulated cell death are a promising strategy for cancer immunotherapy, challenges in overloading these ions to tumor cells without premature release have limited their therapeutic applications. In this study, we develop binary mineral nanoparticles incorporating both Ca<sup>2+</sup> and Na<sup>+</sup> ions to enhance the cytotoxic effects of ion interference in cancer immunotherapy. Engineered using a microfluidic system for uniform size distribution and scalability, these nanoparticles exhibit pH-sensitive ion release. Systemically administered, they preferentially accumulate in tumors, elevating intracellular Ca<sup>2+</sup> and Na<sup>+</sup> levels and inducing immunogenic cell death without calcium channel activators or other small-molecule inducers. Our binary mineral nanoparticles significantly enhance antitumor immunity, especially when combined with an immune checkpoint inhibitor, leading to long-term immunity and inhibition of metastasis. This nanotechnology-enabled synergistic delivery of Ca²⁺ and Na⁺ ions represents a promising adjunct to existing metalloimmunotherapy strategies for cancer eradication.
Medical subject headings
- Immunotherapy
- Calcium
- Nanoparticles
- Sodium
- Neoplasms